Webinar: Enabling biomarker discovery and screening

Multiplex assays allow researchers to measure multiple biomarkers simultaneously, offering the advantage of harvesting more insightful data to inform better decision-making, accelerate research, and increase the probability of discovery. Enabling biomarker discovery and screening with FirePlex Multiplexed Assays features the expertise of Dr Paul Wylie.

In this webinar with Dr Paul Wylie, Director of Multiplex at Abcam, you will learn about High-Throughput FirePlex-384 and 1536 immunoassays for discovery, screening and profiling projects. The webinar includes a case study on a recent publication that used FirePlex 384 in the characterisation of iPSC-derived macrophage cell line.

According to Abcam,  the benefits of High-Throughput FirePlex 384 and 1536 include a no-wash automation-friendly assay workflow; it utilises your existing equipment (High Content Imager); it harvests more data at an earlier stage to improve decision making; and recombinant rabbit monoclonal antibodies (high specificity).

Register now.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free